We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Jul 2022 07:00

RNS Number : 6041R
Sabien Technology Group PLC
07 July 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

7 July 2022

 

Sabien Technology Group plc

("Sabien", the "Company", or the "Group")

Trading Update

Sabien Technology Group plc (AIM:SNT), the company focused on a green aggregation strategy, announces today a trading update ahead of the publication of its final results for the year ended 30 June 2022.

During the year ended 30 June 2022, Sabien's Green Aggregation Strategy has focussed on three principal technology-led initiatives. M2G, the existing Sabien CO2 mitigation device for commercial boilers, the UK rollout of Proton's oil to hydrogen technology, and the COF plastic to oil technology. 

M2G Business

Despite the world semiconductor supply shortage and its impact on the completion of sales during the second half of the 2022 financial year, the Board is very pleased with the growth of the new M2G Cloud business.

During the 2022 financial year, 293 M2G Cloud Solutions were sold (2021: nil) of which 262 (89.4% of the annual total) occurred in the second half of the year. In addition, the Company has deferred revenue of £175k, and open orders of £91k, that will carry over into FY23 as well as £23k of recurring revenue from the M2G Cloud Solutions sold to date to be recognised in FY23. In total, M2G has 2023 revenue identified and charged, but not yet booked, of £289k (July 2021 forward revenue: £43k)

The Board is encouraged that despite the supply chain problems affecting many companies, it has secured revenue which, had it fallen in the year to June 2022 would have resulted in a stable performance year-on-year. It is encouraged, further, that the momentum of revenue is growing through the first half of the Company's financial year to June 2023.

Proton UK Business

Discussions are ongoing with multiple UK oil field owners to identify suitable sites on which to deploy the Proton Technologies Canada Inc. ("Proton") proprietary hydrogen capture technology. In the long term, owners are motivated to develop such hydrogen production facility on their near to end of life fields. The Board believes that this motivation is secular and is likely to grow as the global fuel portfolio adapts to the clear trends in hydrocarbon demand. In the short term, reflecting the current high level of oil prices in the market, field owners have focussed on maximising short term oil production. This has not impacted the momentum behind discussions adversely. The Proton project continues to hold strong prospects for the Group.

COF / b.grn Business

During the financial year to 30 June 2022, the City Oil Field Inc. ("COF") business has been developed in combination with Sabien's development partner b.grn Group Ltd ("b.grn"). Key milestones have been reached including the establishment of a range of partner relationships with funding partners and professional advisors. The latter includes development managers, ESG advisors, and real estate advisors. In consultation with advisers, b.grn has assessed a range of potential sites in England and Wales for the first European COF installation. As previously announced, exclusivity was agreed on a site near Northampton; discussions were held in relation to a site on the Humber Estuary; and most recently an indicative bid was submitted to acquire the ex-Anglesey Aluminium in Anglesey, supported by b.grn funding partners, from the site's administrators. 

Through this work, the Board has developed a strong understanding of the emerging real estate market in key locations in the UK. Within this, the Company and b.grn have developed an advanced assessment of the most efficient sites for the deployment of COF. From this emerging knowledge, the Company and b.grn are now considering actively a number of sites in the UK, and beyond, where b.grn could deploy COF without, necessarily, acquiring the underlying real estate. Investigations into potential sites continue with b.grn's partners. It is likely that the first active deployment will be an initial 24t per day plastic to oil proof of concept plant. 

As a result, the Northampton site's exclusivity has been allowed to lapse. b.grn is not pursuing actively the Humber Estuary site which would have required considerable capital and time investment to make it ready for deployment. Finally, it is b.grn's understanding that it is not one of the leading bidders for the Anglesey Aluminium site on the basis of prices indicated. b.grn awaits any further developments in relation to this site. 

Discussions continue in relation to the Group's option to install a COF site in Saskatchewan on Proton's site. This site has the potential to produce additional benefits in relation to options for the use of offtake oil.

During the year, Sabien charged management fees of £0.15m to b.grn (2021: nil).

Consolidated trading update

The Group's full year consolidated 2022 revenue of £0.83m compares to £0.97m for 2021, a reduction of less than 15%. Sabien has generated consolidated revenue of £0.71m in the second six months of the year under review. This is an increase of 25% on the £0.56m recorded in the same period of 2021. Sabien is also carrying combined revenue of £0.29m into 2023, circa 30% of the total reported in the year to June 2021. A significant component of this carry forward is retained income, giving the Board confidence in the forward visibility of revenue.

As at the balance sheet date, 30 June 2022, Sabien had cash in hand of £0.55m (2021: £1.40m).

Commenting on the 2022 financial year, Richard Parris, Chairman of Sabien, stated:

"During the year under review, despite a challenging supply chain environment, the Company has achieved a solid result for the M2G business once supply chain timing issues are resolved, in addition much development of the COF/b.grn business has been achieved and a fundable business model developed. The Board looks forward to the coming year with considerable confidence.

It is important to remember that the year on which the Board is reporting encompasses two very different trading periods. It is clear to the Board that momentum has accelerated and is building still, notably within M2G and Proton. While COF's development remains more nascent, the Board's knowledge of the available market and the requirements to address it successfully are now well advanced. Sabien enters the year to June 2023 with a confidence backed by results and experience."

For Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman 

 

 +44 20 7993 3700 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNAARUSUBRUR
Date   Source Headline
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace
9th Jan 20247:00 amRNSTrading Update
29th Nov 20231:00 pmRNSResult of AGM
29th Nov 20237:30 amRNSAGM Statement
21st Nov 20231:30 pmRNSHolding(s) in Company
3rd Nov 20234:50 pmRNSHolding(s) in Company
2nd Nov 20231:34 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSFinal Results & Annual Report & Accounts for 2023
1st Nov 20237:15 amRNSUpdate on 2023 Audited Accounts
4th Oct 20237:00 amRNSM2G Rollout in US
26th Sep 20237:00 amRNSProton Technologies
22nd Sep 20236:00 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTrading Update
8th Jun 20237:00 amRNSM2G Business Update
16th May 20237:00 amRNSFurther update on b.grn and related matters
17th Apr 20237:00 amRNSUpdate on b.grn
13th Apr 20239:15 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSDirector/PCA Shareholding
5th Apr 20235:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results for the 6 months to 31 Dec 2022
28th Mar 20237:00 amRNSMaterial M2G Order & Business Update
27th Mar 20237:00 amRNSM2G supports Empiric on net zero goals
10th Mar 202311:33 amRNSHolding(s) in Company
10th Mar 202311:30 amRNSHolding(s) in Company
10th Mar 20237:00 amRNSMaterial M2G order and M2G trading update
28th Feb 20232:45 pmRNSHolding(s) in Company
6th Feb 20234:30 pmRNSHolding(s) in Company
2nd Feb 20234:51 pmRNSHolding(s) in Company
22nd Nov 202212:00 pmRNSResult of AGM
22nd Nov 20227:30 amRNSInvestor Update & Annual General Meeting Statement
18th Nov 20221:46 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSInvestor Update Presentation
2nd Nov 20227:00 amRNSSupply of UK's First Regenerative Green Oil System
24th Oct 20227:00 amRNSOrder Update – New Channel Partner & Customer
17th Oct 20222:47 pmRNSHoling(s) in Company
17th Oct 20221:54 pmRNSHolding(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trae Summit Upate
17th Oct 20227:00 amRNSHoling(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trade Summit Update
17th Oct 20227:00 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSFinal Results for the Year to 30 June 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.